Literature DB >> 10937506

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

M M Gabir1, R L Hanson, D Dabelea, G Imperatore, J Roumain, P H Bennett, W C Knowler.   

Abstract

OBJECTIVE: The 1997 American Diabetes Association (ADA) and the 1985 and 1999 World Health Organization (WHO) criteria for diabetes and hyperglycemia differ. The appropriateness of these diagnostic criteria in terms of individuals identified as abnormal and their prognosis has been debated. The purpose of this study is to compare the classifications of people by these criteria and to compare fasting and postload plasma glucose concentrations in the prediction of diabetes. RESEARCH DESIGN AND METHODS: The frequencies of diabetes by the 3 sets of criteria were compared in 5,023 adult Pima Indians not taking hypoglycemic drugs. Among nondiabetic subjects, fasting plasma glucose (FPG) and 2-h postload plasma glucose (2-h PG) concentrations and categories of impaired glucose regulation or diabetes were evaluated as predictors of diabetes defined by 1999 WHO criteria.
RESULTS: The frequency of diabetes was 12.5% by 1997 ADA criteria, 14.6% by 1985 WHO criteria, and 15.3% by 1999 WHO criteria. The incidence of diabetes was strongly related to higher FPG and 2-h PG, each of which had very similar predictive powers. Impaired glucose tolerance (IGT) was more common than impaired fasting glucose (IFG) (15 vs. 5%), but the 5-year incidence of diabetes was higher in IFG than IGT (37 vs. 24%).
CONCLUSIONS: The prevalence and incidence of diabetes are somewhat lower with the ADA criteria than with the 1985 or 1999 WHO criteria. The intermediate categories of glycemia differ substantially IFG defines a smaller number of people who are at higher risk of developing diabetes than those with IGT. More people at high risk of diabetes could be identified by using either IFG or IGT, as recommended by the 1999 WHO criteria, or by using the FPG concentration alone, but with a lower cutoff value.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937506     DOI: 10.2337/diacare.23.8.1108

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  143 in total

Review 1.  Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

3.  Progression from newly acquired impaired fasting glusose to type 2 diabetes.

Authors:  Gregory A Nichols; Teresa A Hillier; Jonathan B Brown
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

Review 4.  Have we got the new diagnostic criteria for diabetes and impaired glucose states right? Almost.

Authors:  K George M M Alberti
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

5.  Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.

Authors:  Yifei Zhang; Xi Lu; Jie Hong; Menglei Chao; Weiqiong Gu; Weiqing Wang; Guang Ning
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

6.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

7.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

8.  Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.

Authors:  Martin Friedrichsen; Jesper B Birk; Erik A Richter; Rasmus Ribel-Madsen; Christian Pehmøller; Bo Falck Hansen; Henning Beck-Nielsen; Michael F Hirshman; Laurie J Goodyear; Allan Vaag; Pernille Poulsen; Jørgen F P Wojtaszewski
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

9.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

10.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.